Low-dose vs. high-dose cisplatin: lessons learned from 59 chemoradiotherapy trials in head and neck cancer
In locally advanced squamous cell carcinomas of the head and neck (LA-SCCHN),
concurrent chemoradiotherapy is an integral part of multimodality management both in the …
concurrent chemoradiotherapy is an integral part of multimodality management both in the …
Cancer combination therapies with artemisinin-type drugs
T Efferth - Biochemical pharmacology, 2017 - Elsevier
Artemisia annua L. is a Chinese medicinal plant, which is used throughout Asia and Africa
as tea or press juice to treat malaria. The bioactivity of its chemical constituent, artemisinin is …
as tea or press juice to treat malaria. The bioactivity of its chemical constituent, artemisinin is …
Follow-up of head and neck cancer survivors: tipping the balance of intensity
The traditional concept of post-treatment surveillance in head and neck cancer patients
relies on examinations directed at early detection of disease recurrence and/or second …
relies on examinations directed at early detection of disease recurrence and/or second …
Gastrostomy tube dependence and patient‐reported quality of life outcomes based on type of treatment for human papillomavirus‐associated oropharyngeal cancer …
DL Quan, A Sukari, M Nagasaka, H Kim… - Head & …, 2021 - Wiley Online Library
We examined the impact of treatment modality on gastrostomy tube dependence and patient‐
reported outcomes in human papillomavirus‐associated oropharyngeal cancer (HPV …
reported outcomes in human papillomavirus‐associated oropharyngeal cancer (HPV …
Design and fabrication of a 3D–printed oral stent for head and neck radiotherapy from routine diagnostic imaging
Background Oral stents have been shown to reduce the deleterious effects of head and neck
radiotherapy through the displacement of normal tissues away from the areas of high dose …
radiotherapy through the displacement of normal tissues away from the areas of high dose …
Patient‐reported quality‐of‐life outcomes after de‐escalated chemoradiation for human papillomavirus‐positive oropharyngeal carcinoma: Findings from a phase 2 …
JV Hegde, N Shaverdian, ME Daly, C Felix, DL Wong… - Cancer, 2018 - Wiley Online Library
BACKGROUND The current study represents a subset analysis of quality‐of‐life (QOL)
outcomes among patients treated on a phase 2 trial of de‐escalated chemoradiation for …
outcomes among patients treated on a phase 2 trial of de‐escalated chemoradiation for …
Radiation therapy for cT1-2 carcinoma of the palatine tonsil diagnosed via a simple tonsillectomy: Dosimetry and patterns of care in the IMRT era
MC Ward, ML Wallander, JG Kuremsky, R Dhakal… - Oral Oncology, 2023 - Elsevier
Objective Small carcinomas of the palatine tonsil are often diagnosed via simple
tonsillectomy, a maneuver with non-therapeutic intent. Herein, practice patterns for this …
tonsillectomy, a maneuver with non-therapeutic intent. Herein, practice patterns for this …
Long-term outcomes following stereotactic body radiotherapy boost for oropharyngeal squamous cell carcinoma
S Baker, GM Verduijn, S Petit, A Sewnaik, H Mast… - Acta …, 2019 - Taylor & Francis
Background/purpose: To determine the efficacy and toxicity profile of a stereotactic body
radiotherapy (SBRT) boost as a first line treatment in patients with oropharyngeal squamous …
radiotherapy (SBRT) boost as a first line treatment in patients with oropharyngeal squamous …
[HTML][HTML] Prognostic factor analysis and long-term results of the TAX 323 (EORTC 24971) study in unresectable head and neck cancer patients
P Szturz, M Vinches, É Remenár… - European Journal of …, 2021 - Elsevier
Abstract Background In the TAX 323 (EORTC 24971) phase III trial enrolling patients with
unresectable locoregionally advanced squamous cell carcinoma of the head and neck (LA …
unresectable locoregionally advanced squamous cell carcinoma of the head and neck (LA …
Functional outcomes after de-escalated chemoradiation therapy for human papillomavirus–positive oropharyngeal cancer: secondary analysis of a phase 2 trial
Purpose To analyze functional outcomes for patients treated on a phase 2 trial of de-
escalated chemoradiation therapy for human papillomavirus–positive oropharyngeal …
escalated chemoradiation therapy for human papillomavirus–positive oropharyngeal …